ArticleCanadian journal of gastroenterology & hepatology2022

ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma.

Yuanyuan Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.